title: Exposure to rosiglitazone and fluoxetine in the first trimester of pregnancy.
authors.forename: June-Seek
authors.initials: JS
authors.lastname: Choi
authors.forename: Jung-Yeol
authors.initials: JY
authors.lastname: Han
authors.forename: Hyun-Kyong
authors.initials: HK
authors.lastname: Ahn
authors.forename: Joong-Sik
authors.initials: JS
authors.lastname: Shin
authors.forename: Jae-Hyug
authors.initials: JH
authors.lastname: Yang
authors.forename: Mi-Kyoung
authors.initials: MK
authors.lastname: Koong
authors.forename: Alejandro A
authors.initials: AA
authors.lastname: Nava-Ocampo
mesh_terms: D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011256:Pregnancy Outcome; D011261:Pregnancy Trimester, First; D000077154:Rosiglitazone; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000627:therapeutic use*
chemical_list: D005473:Fluoxetine; D007004:Hypoglycemic Agents; D000077154:Rosiglitazone; D017367:Selective Serotonin Reuptake Inhibitors; D045162:Thiazolidinediones